In our hyper-connected world of 2025, where notifications ping endlessly and work bleeds into every hour, sleep feels like a ...

Announced iPSC derived beta islet cell program for Type 1 diabetes (T1D); Investigational New Drug (IND)-enabling studies expected to initiate by ...

Rising demand for cell-based therapies and technological progress in reprogramming support market expansion. Challenges ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient ...

Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune ...

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and ...

We've all had those moments, standing in front of a closet full of perfectly good clothing but still unable to find an outfit we like. In those "I-have-nothing-to-wear" moments, you pull out the ...

If you’ve already started your estate planning, congratulations — you’re ahead of the curve and protecting what matters most! As of 2025, only about 24% of American adults have a will or estate plan, ...